Correlation Between Inozyme Pharma and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Emergent Biosolutions, you can compare the effects of market volatilities on Inozyme Pharma and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Emergent Biosolutions.
Diversification Opportunities for Inozyme Pharma and Emergent Biosolutions
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Inozyme and Emergent is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Emergent Biosolutions
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Emergent Biosolutions. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 2.55 times less risky than Emergent Biosolutions. The stock trades about 0.0 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 210.00 in Emergent Biosolutions on September 15, 2024 and sell it today you would earn a total of 659.00 from holding Emergent Biosolutions or generate 313.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Emergent Biosolutions
Performance |
| Timeline |
| Inozyme Pharma |
| Emergent Biosolutions |
Inozyme Pharma and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Emergent Biosolutions
The main advantage of trading using opposite Inozyme Pharma and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Inozyme Pharma vs. Puma Biotechnology | Inozyme Pharma vs. Iovance Biotherapeutics | Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. Zentalis Pharmaceuticals Llc |
| Emergent Biosolutions vs. Puma Biotechnology | Emergent Biosolutions vs. Iovance Biotherapeutics | Emergent Biosolutions vs. Day One Biopharmaceuticals | Emergent Biosolutions vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |